MedCity News
APRIL 9, 2025
Solu Therapeutics platform technology, which was licensed from GSK, pairs a small molecule with an antibody to address elusive disease targets. Cancer is Solus initial focus, but the startup is also exploring applications of its platform to immunology. The post Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer appeared first on MedCity News.
PharmaVoice
APRIL 9, 2025
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 9, 2025
Through Teladoc’s new cardiometabolic health program, patients gain access to the BetterSleep app, a registered dietitian, health coaches, at-home testing and more. The post Teladoc Health Launches New Cardiometabolic Health Program appeared first on MedCity News.
Pharma Marketing Network
APRIL 9, 2025
Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
APRIL 9, 2025
[Sponsored] Outsourcing your medical coding can help ensure a healthy revenue cycle. Discover the best medical coding outsourcing companies and find the right one for you. The post What Are the Best Medical Coding Outsourcing Companies? appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
APRIL 9, 2025
The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.
PharmaTimes
APRIL 9, 2025
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making
pharmaphorum
APRIL 9, 2025
Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.
PharmaTech
APRIL 9, 2025
SkyCell is working with Microsoft to incorporate SkyCells AI-powered supply chain solution into Microsoft Teams and Copilot.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
APRIL 9, 2025
The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of colorectal cancer
Pharmaceutical Commerce
APRIL 9, 2025
How can stakeholders prepare for changing therapy requirements?
pharmaphorum
APRIL 9, 2025
Jazz Pharma has offered to pay $145m to settle claims it paid to prevent generic versions of its narcolepsy drug Xyrem from reaching the US market.
Pharmaceutical Commerce
APRIL 9, 2025
Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
APRIL 9, 2025
Siemens said spending on AI software is predicted to double by the end of the 2020s, in a market increasingly driven by structural shifts that underscore a need for digital transformation.
Pharmaceutical Commerce
APRIL 9, 2025
A keynote presentation describes how supply chain visibility should rely on digital capabilities.
PharmExec
APRIL 9, 2025
Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was the largest immunotherapy study in patients with previously untreated, unresectable, or metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.
Pharmaceutical Commerce
APRIL 9, 2025
Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
APRIL 9, 2025
The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and promising to reshape the future of precision medicine.
Pharmaceutical Commerce
APRIL 9, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
APRIL 9, 2025
The Inflation Reduction Act (IRA) is expected to influence the clinical development strategies of pharma companies profoundly.
Pharmaceutical Commerce
APRIL 9, 2025
A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product pipelines.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Technology
APRIL 9, 2025
The funding will be used to advance Meridas lead programme in the autoimmune condition, Graves disease.
Pharmaceutical Commerce
APRIL 9, 2025
Respective industry and government agendas could significantly reshape the US prescription drug market.
Pharmaceutical Technology
APRIL 9, 2025
60 Degrees has signed a patent licence agreement with Yale School of Medicine for tafenoquine development for babesiosis.
PharmExec
APRIL 9, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
APRIL 9, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirsts chief medical officer, shares his thoughts on the rumors that RFK Jr. could potentially ban DTC advertising.
PharmExec
APRIL 9, 2025
LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving representative clinical trials for psoriasis, and how they are overcoming them.
Pharmaceutical Technology
APRIL 9, 2025
With liver ailments on the rise, and obesity a key driver, understanding the treatment options available is critical.
Expert insights. Personalized for you.
179 
Let's personalize your content